JANUVIA (Page 8 of 8)

Package/Label Display Panel

Januvia® (sitagliptin) tablets

50 mg

Contains approximately 2340 Tablets

Bottle label
(click image for full-size original)
JANUVIA sitagliptin tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:55154-5040(NDC:0006-0112)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SITAGLIPTIN PHOSPHATE (SITAGLIPTIN) SITAGLIPTIN 50 mg
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS DIBASIC CALCIUM PHOSPHATE
CROSCARMELLOSE SODIUM
magnesium stearate
MICROCRYSTALLINE CELLULOSE
POLYETHYLENE GLYCOL, UNSPECIFIED
POLYVINYL ALCOHOL, UNSPECIFIED
FERRIC OXIDE RED
SODIUM STEARYL FUMARATE
talc
titanium dioxide
FERRIC OXIDE YELLOW
Product Characteristics
Color BROWN (light beige) Score no score
Shape ROUND (round) Size 8mm
Flavor Imprint Code 112
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:55154-5040-8 2340 TABLET, FILM COATED in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021995 10/16/2006
Labeler — Cardinal Health (603638201)

Revised: 03/2022 Cardinal Health

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.